Want to see ZEPP full AI Analyst Report?
ZEPP Stock Chart & Stats
$4.90
-$0.06(-1.22%)
At close: 4:00 PM EDT
$4.90
-$0.06(-1.22%)
Day’s Range― - ―
52-Week Range$3.85 - $61.85
Previous CloseN/A
Volume21.80K
Average Volume (3M)70.25K
Market Cap
$75.60M
Enterprise Value$325.95
Total Cash (Recent Filing)$709.95M
Total Debt (Recent Filing)$1.65B
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-217.83
Shares Outstanding8,460,126
10 Day Avg. Volume33,956
30 Day Avg. Volume70,254
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.02
Price to Sales (P/S)0.01
P/FCF Ratio-0.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$53.01Price Target Upside981.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)$331.24M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And PremiumizationStrong revenue growth alongside higher average selling prices indicates improving product mix and demand for premium devices, which can support more durable sales quality and margin potential than volume-led expansion alone.
Brand And Ecosystem ExpansionThe HYROX partnership strengthens Amazfit’s credibility in performance fitness and broadens its ecosystem across watches, rings, glasses and cameras, creating longer-term opportunities for engagement, cross-selling and brand differentiation.
Improving Operating EfficiencyNarrower operating losses, resilient gross margin and lower inventory show progress in scaling the business and managing working capital. If sustained, these improvements could reduce cash needs and support the path toward profitability.
Bears Say
Persistent UnprofitabilityZepp remains materially loss-making despite revenue and margin improvements. Continued losses limit internally funded investment, increase reliance on liquidity and financing, and make the turnaround dependent on sustained execution.
Negative Free Cash FlowThe absence of consistently positive free cash flow indicates that operations are not yet self-funding. Persistent cash burn could constrain product development, marketing and debt reduction while requiring continued balance-sheet support.
Leverage And Cost PressureHigher leverage reduces financial flexibility while component-cost inflation threatens gross-margin recovery. Together, these pressures may slow the transition to profitability and leave less capacity to absorb execution or demand setbacks.
Zepp Health News
ZEPP FAQ
What was Zepp Health Corporation’s price range in the past 12 months?
Zepp Health Corporation lowest stock price was $3.85 and its highest was $61.85 in the past 12 months.
What is Zepp Health Corporation’s market cap?
Zepp Health Corporation’s market cap is $75.60M.
When is Zepp Health Corporation’s upcoming earnings report date?
Zepp Health Corporation’s upcoming earnings report date is Sep 01, 2026 which is in 7 days.
How were Zepp Health Corporation’s earnings last quarter?
Zepp Health Corporation released its earnings results on Jun 09, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Zepp Health Corporation overvalued?
According to Wall Street analysts Zepp Health Corporation’s price is currently Undervalued.
Does Zepp Health Corporation pay dividends?
Zepp Health Corporation pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Zepp Health Corporation dividends here
What is Zepp Health Corporation’s EPS estimate?
Zepp Health Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health Corporation have?
Zepp Health Corporation has 8,460,126 shares outstanding.
What happened to Zepp Health Corporation’s price movement after its last earnings report?
Zepp Health Corporation reported an EPS of -$0.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -28.641%.
Which hedge fund is a major shareholder of Zepp Health Corporation?
Currently, no hedge funds are holding shares in ZEPP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zepp Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.01 (981.84% Upside)
$53.01 (981.84% Upside)
Blogger Sentiment
Bullish
ZEPP Sentiment 100%
Sector Average 59%
Sector Average 59%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.24%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.67%
Trailing 12-Months
Company Description
Zepp Health Corporation
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
ZEPP Company Deck
ZEPP Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational narrative: strong top-line performance with Q1 revenue up 33.8% YoY, meaningful premiumization (ASP +20% YoY), gross profit expansion (up 35.3%) and market share gains supported by new product launches and a strategic 3‑year HYROX partnership. Management also demonstrated progress on expense discipline (operating loss narrowed) and working capital (inventory down). Key near-term challenges include rising memory costs, unfavorable FX impacts, elevated operating expenses from front‑loaded launches/marketing, sequential margin moderation from a Q4 peak, and potential shipment timing risk that could shift revenue across quarters. Overall, the positive revenue, premiumization, margin resilience YoY and strategic partnerships outweigh the challenges, but the company remains on a path toward profitability rather than currently profitable.View all ZEPP earnings summariesZEPP Stock 12 Month Forecast
Average Price Target
$53.01
▲(981.84% Upside)
Technical Analysis
Ownership Overview
12.61% Insiders
3.60% Mutual Funds
2.80% Other Institutional Investors
80.66% Public Companies and
Individual Investors